{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:36:57Z","timestamp":1791196617590,"version":"4.1.0"},"reference-count":26,"publisher":"American Society for Microbiology","issue":"11","content-domain":{"domain":["asm.org"],"crossmark-restriction":true},"short-container-title":["J. Virol."],"published-print":{"date-parts":[[1998,11,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>In the present study, we established an in vitro system representing the Burkitt\u2019s lymphoma (BL)-type Epstein-Barr virus (EBV) infection which is characterized by expression of EBV-determined nuclear antigen 1 (EBNA-1) and absence of EBNA-2 and latent membrane protein 1 (LMP1) expression. EBV-negative cell clones isolated from the EBV-positive BL line Akata were infected with an EBV recombinant carrying a selectable marker, and the following selection culture easily yielded EBV-infected clones. EBV-reinfected clones showed BL-type EBV expression and restored the capacity for growth on soft agar and tumorigenicity in SCID mice that were originally retained in parental EBV-positive Akata cells and lost in EBV-negative subclones. Moreover, it was found that EBV-positive cells were more resistant to apoptosis than were EBV-negative cells. EBV-infected cells expressed the <jats:italic>bcl-2<\/jats:italic> protein, through which cells might become resistant to apoptosis, at a higher level than did uninfected cells. This is the first report that BL-type EBV infection confers apoptosis resistance even in the absence of expression of LMP1 and BHRF1, both of which are known to have an antiapoptotic function. Surprisingly, transfection of the EBNA-1 gene into EBV-negative Akata clones could not restore malignant phenotypes and apoptosis resistance, thus suggesting that EBNA-1 alone was not sufficient for conferring them. Our results suggest that the persistence of EBV in BL cells is required for the cells to be more malignant and apoptosis resistant, which underlines the oncogenic role of EBV in BL genesis.<\/jats:p>","DOI":"10.1128\/jvi.72.11.9150-9156.1998","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T18:04:02Z","timestamp":1577815442000},"page":"9150-9156","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":139,"title":["Epstein-Barr Virus Contributes to the Malignant Phenotype and to Apoptosis Resistance in Burkitt\u2019s Lymphoma Cell Line Akata"],"prefix":"10.1128","volume":"72","author":[{"given":"Jun","family":"Komano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenzo","family":"Takada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"B1_20200408120255","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1128\/JVI.66.5.2689-2697.1992","article-title":"Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts","volume":"66","author":"Brooks","year":"1992","journal-title":"J. Virol."},{"key":"B2_20200408120255","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/bjs.18004619704","article-title":"A sarcoma involving the jaws in African children","volume":"46","author":"Burkitt","year":"1958","journal-title":"Br. J. Surg."},{"key":"B3_20200408120255","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.177.2.339","article-title":"Epstein-Barr virus and Hodgkin\u2019s disease: transcriptional analysis of virus latency in the malignant cells","volume":"177","author":"Deacon","year":"1993","journal-title":"J. Exp. Med."},{"key":"B4_20200408120255","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","article-title":"Virus particles in cultured lymphoblasts from Burkitt\u2019s lymphoma","volume":"i","author":"Epstein","year":"1964","journal-title":"Lancet"},{"key":"B5_20200408120255","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1073\/pnas.59.1.94","article-title":"Relation of Burkitt\u2019s tumor-associated herpes-type virus to infectious mononucleosis","volume":"59","author":"Henle","year":"1968","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"B6_20200408120255","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/978-3-642-67236-1_13","article-title":"The virus as the etiologic agent of infectious mononucleosis","volume-title":"The Epstein-Barr virus.","author":"Henle","year":"1979"},{"key":"B7_20200408120255","doi-asserted-by":"crossref","first-page":"9131","DOI":"10.1073\/pnas.91.19.9131","article-title":"Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein","volume":"91","author":"Imai","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"B8_20200408120255","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1128\/JVI.72.5.4371-4378.1998","article-title":"Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells","volume":"72","author":"Imai","year":"1998","journal-title":"J. Virol."},{"key":"B9_20200408120255","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1128\/JVI.67.8.5068-5074.1993","article-title":"Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B","volume":"67","author":"Longnecker","year":"1993","journal-title":"J. Virol."},{"key":"B10_20200408120255","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1128\/MCB.8.7.2837","article-title":"Epstein-Barr virus shuttle vector for stable episomal replication of cDNA expression libraries in human cells","volume":"8","author":"Margolskee","year":"1988","journal-title":"Mol. Cell. Biol."},{"key":"B11_20200408120255","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1073\/pnas.70.11.3265","article-title":"DNA of Epstein-Barr virus detected in tissue of Burkitt\u2019s lymphoma and nasopharyngeal carcinoma","volume":"70","author":"Nonoyama","year":"1973","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"B12_20200408120255","first-page":"2397","article-title":"Epstein-Barr virus","volume-title":"Virology","author":"Rickinson","year":"1996","edition":"3rd ed."},{"key":"B13_20200408120255","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1128\/JVI.68.3.1449-1458.1994","article-title":"An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro","volume":"68","author":"Robertson","year":"1994","journal-title":"J. Virol."},{"key":"B14_20200408120255","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1002\/j.1460-2075.1987.tb02568.x","article-title":"Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt\u2019s lymphoma cells","volume":"6","author":"Rowe","year":"1987","journal-title":"EMBO J."},{"key":"B15_20200408120255","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/(SICI)1096-9896(199611)180:3<243::AID-PATH655>3.0.CO;2-7","article-title":"Enhanced malignant progression of nasopharyngeal carcinoma cells mediated by the expression of Epstein-Barr nuclear antigen 1 in vivo","volume":"180","author":"Sheu","year":"1996","journal-title":"J. Pathol."},{"key":"B16_20200408120255","first-page":"769","article-title":"Epstein-Barr virus-associated gastric adenocarcinoma","volume":"140","author":"Shibata","year":"1992","journal-title":"Am. J. Pathol."},{"key":"B17_20200408120255","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1128\/JVI.68.9.6069-6073.1994","article-title":"Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt\u2019s lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV","volume":"68","author":"Shimizu","year":"1994","journal-title":"J. Virol."},{"key":"B18_20200408120255","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.1128\/JVI.70.10.7260-7263.1996","article-title":"Clonal propagation of Epstein-Barr virus (EBV) recombinants in EBV-negative Akata cells","volume":"70","author":"Shimizu","year":"1996","journal-title":"J. Virol."},{"key":"B19_20200408120255","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/bjc.1996.412","article-title":"Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumor cells","volume":"74","author":"Sugiura","year":"1996","journal-title":"Br. J. Cancer"},{"key":"B20_20200408120255","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1073\/pnas.88.4.1546","article-title":"Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro","volume":"88","author":"Swaminathan","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"B21_20200408120255","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00571929","article-title":"An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA","volume":"5","author":"Takada","year":"1991","journal-title":"Virus Genes"},{"key":"B22_20200408120255","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1128\/JVI.63.1.445-449.1989","article-title":"Synchronous and sequential activation of latently infected Epstein-Barr virus genomes","volume":"63","author":"Takada","year":"1989","journal-title":"J. Virol."},{"key":"B23_20200408120255","doi-asserted-by":"crossref","first-page":"7374","DOI":"10.1128\/JVI.68.11.7374-7385.1994","article-title":"Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state","volume":"68","author":"Tierney","year":"1994","journal-title":"J. Virol."},{"key":"B24_20200408120255","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1002\/j.1460-2075.1996.tb00674.x","article-title":"Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice","volume":"15","author":"Wilson","year":"1996","journal-title":"EMBO J."},{"key":"B25_20200408120255","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1002\/j.1460-2075.1995.tb00040.x","article-title":"Persistent Epstein-Barr virus infection in a human T-cell line: unique program of latent virus expression","volume":"14","author":"Yoshiyama","year":"1995","journal-title":"EMBO J."},{"key":"B26_20200408120255","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/2281056a0","article-title":"EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx","volume":"228","author":"zur Hausen","year":"1970","journal-title":"Nature"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1128\/JVI.72.11.9150-9156.1998","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T19:56:09Z","timestamp":1627588569000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.72.11.9150-9156.1998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,11,1]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1998,11,1]]}},"alternative-id":["10.1128\/JVI.72.11.9150-9156.1998"],"URL":"https:\/\/doi.org\/10.1128\/jvi.72.11.9150-9156.1998","archive":["LOCKSS"],"relation":{},"ISSN":["1098-5514","0022-538X"],"issn-type":[{"value":"1098-5514","type":"electronic"},{"value":"0022-538X","type":"print"}],"subject":[],"published":{"date-parts":[[1998,11,1]]}}}